Company: XAIR
Filing Date: 2025-06-20
Form Type: 10-K
Source: 0001641172-25-015750
Chunk: 375

Company: Beyond Air, Inc.
Filing Date: 2025-06-20
Form: 10-K
Item: Item 16
Chunk 375
---
 
    $(39,159) 
    $(9,197) 
    $(123) 
    $(48,479)
  
    Operating activities included in net loss: 

    Depreciation and amortization 
    $3,143  
    $61  
    $-  
    $3,204 
  
    Stock-based compensation expense 
    $7,920  
    $1,154  
    $72  
    $9,146 

    Cash used in operations 
    $(29,599) 
    $(8,619) 
    $-  
    $(38,218)
  
    Cash from investing 
     11,844  
     3,061  
     -  
     14,905 
  
    Cash from financing 
     14,646  
     -  
     2,000  
     16,646 
  
    Impact of exchange rates 
     (39) 
     (6) 
     -  
     (45)
  
    Net change for the year 
    $(3,148) 
    $(5,564) 
    $2,000  
    $(6,712)

    F-32

BEYOND AIR, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTE 14 VARIABLE INTEREST
ENTITIES (continued)

The following table summarizes segment financial information
by business segment for the year ended and at March 31, 2024:

 SCHEDULE
OF SEGMENT FINANCIAL INFORMATION BY BUSINESS SEGMENT

    (in thousands) 
    Beyond Air  
    Beyond Cancer  
     NeuroNos  
    Total 
  
    Cash, cash equivalents and marketable securities 
    $23,591  
    $10,877  
    $      -  
    $34,468 
  
    All other assets 
     21,747  
     746  
     -  
     22,493 
  
    Total assets 
    $45,338  
    $11,623  
    $-  
    $56,961 
  
    Total liabilities 
     (28,810) 
     (965) 
     -  
     (29,775)
  
    Net assets 
    $16,528  
    $10